Zhiwei Q. Chang
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Phase Ib Trial of Finotonlimab Combined With SCT200 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
Journal: Cancer medicine
Published: November 10, 2025
Detection of circulating hybrid cells and circulating tumor cells in cerebrospinal fluid for leptomeningeal metastasis diagnosis and therapeutic prediction.
Journal: Frontiers in cell and developmental biology
Published: September 30, 2025
Optimizing Postoperative Management in Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Gastroesophageal Junction Adenocarcinoma: A Multicenter Retrospective Study.
Journal: Journal of gastric cancer
Published: September 21, 2025
Phase Ib study of SCT200 combined with paclitaxel or docetaxel in patients with recurrent or metastatic head and neck squamous cell carcinoma following platinum-based chemotherapy and PD-1 antibody.
Journal: Cancer letters
Published: December 11, 2024
Feasibility and tolerability of anlotinib plus PD-1 blockades as rechallenge immunotherapy in previously treated advanced ESCC: a retrospective study.
Journal: The oncologist
Published: May 31, 2024
Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 06, 2024
PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.
Journal: Biology direct
Published: October 08, 2023
PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study.
Journal: JCO precision oncology
Published: March 30, 2023
NALCN is a potential biomarker and therapeutic target in human cancers.
Journal: Frontiers in genetics
Published: February 13, 2023
Macrophage-derived exosomes regulate gastric cancer cell oxaliplatin resistance by wrapping circ 0008253.
Journal: Cell cycle (Georgetown, Tex.)
Published: November 23, 2022
The Optimal Therapy after Progression on Immune Checkpoint Inhibitors in MSI Metastatic Gastrointestinal Cancer Patients: A Multicenter Retrospective Cohort Study.
Journal: Cancers
Published: September 11, 2022
Last Updated: 09/26/2026